Tag Archives: Promentis Pharmaceuticals

Company founded by two Marquette University researchers raises $26 million in funding

News release, April 10, 2017

Promentis Pharmaceuticals, a Milwaukee company co-founded by Drs. John Mantsch and David Baker, researchers from the Marquette University College of Health Sciences, raised $26 million, including $17.2 million in its third funding round. OrbiMed, F-Prime Capital Partners (formerly Fidelity Biosciences) and Aisling Capital were the lead investors. This is exceptional syndicate of investors, particularly for […]

Continue...